Fig. 3From: The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancerSurvival curves with the log-rank tests of overall survival per metastatic sites according to subtype; HR+/HER2-(a), HR+/HER2 + (b), HR−/HER2 + (c), TN (d). Abbreviations: HR: Hormone receptor, HER2: Human epidermal growth receptor 2, TN: Triple negativeBack to article page